Explore the Role of the rs1801133-PPARG Pathway in the H-type Hypertension
Both rs1801133 mutation on Methylenetetrahydrofolate reductase (MTHFR) gene and transcription factor peroxisome proliferator-activated gamma (PPARG) have been associated with plasma homocysteine (Hcy) levels and hypertension. However, their role in H-type hypertension remains unclear. In this study,...
Saved in:
Main Authors: | Xiuwen Liang, Tingting He, Lihong Gao, Libo Wei, Di Rong, Yu Zhang, Yu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2022/2054876 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Association Between Methylenetetrahydrofolate Reductase (Rs1801131 and Rs1801133) Gene Polymorphisms and Severity of Coronary Lesions in Patients With STEMI and NSTEMI: A Retrospective Cross‐Sectional Study
by: Behnam Nazarzadeh, et al.
Published: (2025-01-01) -
PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis
by: Lina Sabatino, et al.
Published: (2012-01-01) -
Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma
by: Meng Lian, et al.
Published: (2020-01-01) -
Nuclear Protein 1 Expression Is Associated with PPARG in Bladder Transitional Cell Carcinoma
by: Chao Lu, et al.
Published: (2023-01-01) -
Role of PPARG in Chemosensitivity-Regulating Network for Hypopharyngeal Squamous Cell Carcinoma
by: Fanyong Kong, et al.
Published: (2023-01-01)